Clinical Utility of ClarityDX Prostate

Clinical trial NCT06678828 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06678828
Sponsor: Nanostics
Status: ENROLLING_BY_INVITATION
Phase: Not Applicable
Study type: INTERVENTIONAL

Prostate Cancer Prostate Cancer Screening Decision Prostate Cancer Screening

Start date: 2025-04-14
Primary completion: 2028-10-01
Enrollment: 1450

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.